TrialCNS drugs2020

Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.

Nakao Iwata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.